Ideaya Biosciences

We track 4 ClinicalTrials.gov studies led by Ideaya Biosciences. The portfolio skews toward Phase 1 (4 trials).

4 clinical trials sponsored by Ideaya Biosciences.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 4
100%

Trial Status Breakdown

Trials by Ideaya Biosciences

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

NCT07277413 · RECRUITING · Phase 1

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

NCT07277413 · RECRUITING · Phase 1

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

NCT07503808 · RECRUITING · Phase 1

An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors

NCT04794699 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Ideaya Biosciences sponsor?

Ideaya Biosciences currently sponsors 4 clinical trials tracked on ReadTheTrial. These span Phase 1.

What conditions does Ideaya Biosciences research?

Ideaya Biosciences conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Ideaya Biosciences recruiting for clinical trials?

Yes, Ideaya Biosciences currently has 3 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More